Canopy Growth (CGC) Operating Expenses (2019 - 2025)
Canopy Growth (CGC) reported Operating Expenses of $91.3 million for Q4 2025, up 166.06% on a YoY basis from $34.3 million in Q4 2024, and up 223.73% sequentially from $28.2 million in Q3 2025.
Canopy Growth (CGC) Operating Expenses (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Operating Expenses data on file, last reported at $91.3 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 166.06% year-over-year to $91.3 million; the trailing twelve-month figure through Mar 2026 stood at $148.8 million (up 21.86% YoY), and the FY2026 full-year result was $168.7 million, up 23.08% from the prior year.
- Operating Expenses climbed to $91.3 million in Q4 2025, from $28.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.4 billion in Q2 2022 to a low of $22.7 million in Q3 2023.
- A 5-year average of $176.4 million and a median of $90.7 million in 2024 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses jumped 723.89% in 2022 and slumped 96.46% in 2023, its largest moves.
- Tracing CGC's Operating Expenses over 5 years: stood at $127.0 million in 2021, then slumped by 31.58% to $86.9 million in 2022, then slipped by 25.13% to $65.0 million in 2023, then tumbled by 47.26% to $34.3 million in 2024, then soared by 166.06% to $91.3 million in 2025.
- Business Quant data shows CGC's Operating Expenses at $91.3 million in Q4 2025, $28.2 million in Q3 2025, and $29.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.27 Mn |
| Sep 30, 2025 | 28.19 Mn |
| Jun 30, 2025 | 29.35 Mn |
| Dec 31, 2024 | 34.30 Mn |
| Sep 30, 2024 | 49.69 Mn |
| Jun 30, 2024 | 38.12 Mn |
| Mar 31, 2024 | 90.69 Mn |
| Dec 31, 2023 | 65.04 Mn |
| Sep 30, 2023 | 22.70 Mn |
| Jun 30, 2023 | 50.93 Mn |
| Mar 31, 2023 | 355.39 Mn |
| Dec 31, 2022 | 86.87 Mn |
| Sep 30, 2022 | 113.91 Mn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 246.45 Mn |
| Dec 31, 2021 | 126.97 Mn |
| Sep 30, 2021 | 114.57 Mn |
| Jun 30, 2021 | 174.87 Mn |
| Mar 31, 2021 | 192.00 Mn |
| Dec 31, 2020 | 443.51 Mn |